dc.contributor.author | Sever, Lale | |
dc.contributor.author | Koc, Basak | |
dc.contributor.author | Adaletli, Ibrahim | |
dc.contributor.author | Emir, Haluk | |
dc.contributor.author | Caliskan, Salim | |
dc.contributor.author | Canpolat, Nur | |
dc.date.accessioned | 2021-03-02T16:48:21Z | |
dc.date.available | 2021-03-02T16:48:21Z | |
dc.date.issued | 2020 | |
dc.identifier.citation | Koc B., Canpolat N., Adaletli I., Sever L., Emir H., Caliskan S., "Efficacy of tolterodine in children with overactive bladder.", Turk pediatri arsivi, cilt.55, sa.3, ss.284-289, 2020 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_72509506-d969-43b8-86fa-ce03dfcfb78c | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/3368 | |
dc.identifier.uri | https://doi.org/10.14744/turkpediatriars.2020.98215 | |
dc.description.abstract | Aim: Tolterodine is an anticholinergic drug used for the treatment of overactive bladder. We evaluated the effects of tolterodine on clinical symptoms and compared its efficacy with that of oxybutynin in terms of bladder capacity, bladder wall thickness, and post-void residual volume in children with overactive bladder. | |
dc.language.iso | eng | |
dc.subject | Tıp | |
dc.subject | Çocuk Sağlığı ve Hastalıkları | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | PEDİATRİ | |
dc.title | Efficacy of tolterodine in children with overactive bladder. | |
dc.type | Makale | |
dc.relation.journal | Turk pediatri arsivi | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 55 | |
dc.identifier.issue | 3 | |
dc.identifier.startpage | 284 | |
dc.identifier.endpage | 289 | |
dc.contributor.firstauthorID | 2286050 | |